On September 26, Golonghui announced that its wholly-owned subsidiary, Oriental Ocean Life Technology Co., Ltd. (referred to as "Eastern Ocean Life Technology"), jointly invested with Shandong Yino Medical Technology Co., Ltd. to establish: Shandong Oriental Hong Biotechnology Co., Ltd., with a registered capital of RMB 3 million, of which Eastern Ocean Life Technology needs to contribute 51% of the registered capital, amounting to RMB 1.53 million; Shandong Yino Medical Technology Co., Ltd. needs to contribute 49% of the registered capital, amounting to RMB 1.47 million.

Oriental Ocean Life Technology jointly invested with Fuzhou Yudi Trading Co., Ltd. to establish: Fuzhou Oriental Yudi Trading Co., Ltd., with a registered capital of RMB 2 million, of which Oriental Ocean Life Technology needs to contribute 51% of the registered capital, amounting to RMB 1.02 million; Fuzhou Yudi Trading Co., Ltd. needs to contribute 49% of the registered capital, amounting to RMB 0.98 million.

The establishment of the joint venture company this time aims to fully leverage the strengths of all parties and jointly build a product distribution platform and terminal intensive platform with the cooperation partner to enhance the company's influence in the large health sector; leveraging the cooperation partner's modern brand and sales channels, expand the company's large health product structure and quickly promote the company's self-product sales in the large health sector; relying on the cooperation partner's team to improve the company's large health after-sales system; utilizing the cooperation partner's resources to supplement the expert pool.